News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Suda Pharmaceuticals.
RELATED STOCKHEAD STORIES
News
Weed Week: Illinois legalises recreational pot use… and now, the US Feds can’t interfere
Health & Biotech
Weed Week: Here comes the latest hot take on legal dope from… the Country Women’s Association
News
Weekly ASX small cap wrap: Who’s decided to rock the world this week?
Health & Biotech
Biotech entrepreneur Paul Hopper tells us why he joined ‘treasure chest’ Suda
News
Lunchtime ASX small cap wrap: Who’s all business at the front, party at the back today?
Health & Biotech
Health: Get a load of this new brain scanner that Compumedics has installed
Health & Biotech
Suda Pharmaceuticals just got some bad news about its anti-malaria mouth spray
Health & Biotech
Health: Neurotech fires a strategic adviser after claims he’s a dud, shares fall 17pc
Health & Biotech
Pot stock Zelda is coming to America – someday – after signing a pharma deal
Health & Biotech
Weed week: In Canada pot is hot; in Australia it’s just a steady glow
Health & Biotech
This health small cap has grown by more than 8000pc in the last decade
News
Lunchtime ASX small cap wrap: who’s laughing all the way to the bank today
Health & Biotech
Suda signs deal with $936bn pharma company to sell its insomnia spray
Health & Biotech
Zelda and viagra mouth spray maker Suda team up to do pot
Health & Biotech
Check up: here’s what’s happening with 140 ASX small cap health stocks
News
Lunchtime ASX small cap wrap: who’s going for a hole-in-one
Health & Biotech
